SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY
2013-01-01 Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Daprada, G; Fregoni, V; Pavesi, L; Riccardi, A; Zucchetti, M; D'Incalci, M; Zambelli, A
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM)
2015-01-01 Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P
miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup
2013-01-01 Calura, E; Fruscio, R; Paracchini, L; Bignotti, E; Martini, P; Ravaggi, A; Di Marino, M; Sales, G; Beltrame, L; Dell'Orto, F; Baldo, R; Pecorelli, S; Sartori, E; Zanotti, L; Katsaros, D; Tognon, G; D'Incalci, M; Romualdi, C; Marchini, S
EPOC-experiences - conducting a multinational clinical trial on the pharmacology of doxorubicin in children with cancer
2013-01-01 Krischke, M; Andre, N; Boddy, A; Bode, G; D'Incalci, M; Hempel, G; Kontny, N; Steel, A; Voller, V; Boos, J
Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis
2013-01-01 Ansaloni, L; Busci, Lm; Coccolini, F; Grosso, G; Lotti, M; Morosi, L; Poiasina, E; Zucchetti, M; D'Incalci, M; Frigerio, L
RANDOMIZED, NON-COMPARATIVE, PHASE II TRIAL OF BEVACIZUMAB AND TRABECTEDIN WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER (ROC) WOMEN
2017-01-01 Colombo, N; Nicoletto, Mo; Lissoni, A; Scambia, G; Tognon, G; Negri, E; Galli, F; Biagioli, E; Rulli, E; Fossati, R; D'Incalci, M
AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER
2014-01-01 Gerardi, C; Floriani, I; Biagioli, E; D'Incalci, M; Fossati, R; Colombo, N
Fsn0503h antibody-mediated blockade of cathepsin S as potential therapeutic strategy for the treatment of solid tumors
2013-01-01 Vazquez, R; Astorgues-Xerri, L; Cvitkovic, E; Bekradda, M; Fleck, R; Gormley, J; Buick, R; Kerr, P; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera
2014-01-01 Uboldi, S; Frapolli, R; Bello, E; Brich, S; Bozzi, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Galmarini, Cm; Sousa-Faro, Jmf; Pilotti, S; D'Incalci, M
MIRNA181A-5P EXPRESSION AS A BIOMARKER OF TGFB PATHWAY ACTIVATION ASSOCIATED WITH ONCOLOGIC OUTCOME AND TUMOR DIFFUSION IN HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER
2017-01-01 Ceppi, L; Palazzi, S; Romualdi, C; Dilorenzo, P; Grassi, T; Biagioli, E; Paracchini, L; Milani, R; Buda, A; D'Incalci, M; Marchini, S; Fruscio, R
In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells
2015-01-01 Lupi, M; Falcetta, F; D'Incalci, M; Ubezio, P
Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study
2016-01-01 Ferrari, M; Grosso, F; Grignani, G; Ibrahim, T; Tamberi, S; Marra, D; Marchesi, E; Porcu, L; D'Incalci, M; Zucchetti, M
MIRNA LANDSCAPE IN STAGE I EPITHELIAL OVARIAN CANCER DEFINES THE HISTOTYPE SPECIFICITIES
2013-01-01 Bignotti, E; Calura, E; Fruscio, R; Paracchini, L; Ravaggi, A; Zanotti, L; Tognon, G; D'Incalci, M; Sartori, E; Pecorelli, S
MICRORNA PROFILE IN BONE MARROW FIBROBLASTS FROM PATIENTS WITH MULTIPLE MYELOMA
2015-01-01 Desantis, V; Caparrotta, I; Beltrame, L; Di Marzo, L; Marchini, S; Catacchio, I; D'Incalci, M; Vacca, A; Frassanito, Ma
DIAGNOSTIC AND PROGNOSTIC IMPACT OF MICRORNA EXPRESSION IN SERUM OF HIGH-GRADE SEROUS OVARIAN CARCINOMA PATIENTS
2015-01-01 Bignotti, E; Todeschini, P; Ravaggi, A; Ferracin, M; Sartori, E; Odicino, F; Tognon, G; Negrini, M; D'Incalci, M; Marchini, S; Romualdi, C
Pharmacokinetics of the Novel FGFR and VEGFR Inhibitor, E-3810, in Patients with Advanced Solid Tumors Participating to a Phase I/II Trial
2012-01-01 Zangarini, M; Sala, F; Camboni, Mg; Cereda, R; Livi, V; Bahleda, R; Dienstmann, R; Delmonte, A; D'Incalci, M; Zucchetti, M
OTX015 effects in triple-negative breast cancer (TNBC) models are independent of hypoxia conditions and synergistic with other anticancer agents
2015-01-01 Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Beltrame, L; Marchini, S; Bertoni, F; Kwee, I; Mohamed, M; Cvitkovic, E; Frapolli, R; D'Incalci, M
CIRCULATING MIRNA LANDSCAPE IDENTIFIES MIR-1246 AS PROMISING DIAGNOSTIC BIOMARKER IN HIGH-GRADE SEROUS OVARIAN CARCINOMA: A VALIDATION ACROSS TWO INDEPENDENT COHORTS
2017-01-01 Bignotti, E; Todeschini, P; Salviato, E; Paracchini, L; Ferracin, M; Petrillo, M; Zanotti, L; Tognon, G; Gambino, A; Calura, E; Beltrame, L; Odicino, F; Sartori, E; Scambia, G; Negrini, M; Ravaggi, A; D'Incalci, M; Marchini, S; Romualdi, C
Activation of TGF-Beta Pathway Through Mir-181a and Psmad-2 Overexpression Drives Resistance To Neoadjuvant Chemotherapy in High Grade Serous Advanced Ovarian Cancer
2015-01-01 Petrillo, M; Marchini, S; Romualdi, C; Beltrame, L; Martinelli, E; Difeo, A; D'Incalci, M; Zannoni, Gf; Scambia, G
Insulin-like growth factor binding protein-4 (IGFBP-4) tumor and serum levels are increased across all stages of epithelial ovarian cancer
2012-01-01 Mosig, R; Lobl, M; Cohen, S; Chudin, E; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, J
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY | 1-gen-2013 | Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Daprada, G; Fregoni, V; Pavesi, L; Riccardi, A; Zucchetti, M; D'Incalci, M; Zambelli, A | |
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) | 1-gen-2015 | Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P | |
miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup | 1-gen-2013 | Calura, E; Fruscio, R; Paracchini, L; Bignotti, E; Martini, P; Ravaggi, A; Di Marino, M; Sales, G; Beltrame, L; Dell'Orto, F; Baldo, R; Pecorelli, S; Sartori, E; Zanotti, L; Katsaros, D; Tognon, G; D'Incalci, M; Romualdi, C; Marchini, S | |
EPOC-experiences - conducting a multinational clinical trial on the pharmacology of doxorubicin in children with cancer | 1-gen-2013 | Krischke, M; Andre, N; Boddy, A; Bode, G; D'Incalci, M; Hempel, G; Kontny, N; Steel, A; Voller, V; Boos, J | |
Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis | 1-gen-2013 | Ansaloni, L; Busci, Lm; Coccolini, F; Grosso, G; Lotti, M; Morosi, L; Poiasina, E; Zucchetti, M; D'Incalci, M; Frigerio, L | |
RANDOMIZED, NON-COMPARATIVE, PHASE II TRIAL OF BEVACIZUMAB AND TRABECTEDIN WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER (ROC) WOMEN | 1-gen-2017 | Colombo, N; Nicoletto, Mo; Lissoni, A; Scambia, G; Tognon, G; Negri, E; Galli, F; Biagioli, E; Rulli, E; Fossati, R; D'Incalci, M | |
AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER | 1-gen-2014 | Gerardi, C; Floriani, I; Biagioli, E; D'Incalci, M; Fossati, R; Colombo, N | |
Fsn0503h antibody-mediated blockade of cathepsin S as potential therapeutic strategy for the treatment of solid tumors | 1-gen-2013 | Vazquez, R; Astorgues-Xerri, L; Cvitkovic, E; Bekradda, M; Fleck, R; Gormley, J; Buick, R; Kerr, P; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me | |
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera | 1-gen-2014 | Uboldi, S; Frapolli, R; Bello, E; Brich, S; Bozzi, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Galmarini, Cm; Sousa-Faro, Jmf; Pilotti, S; D'Incalci, M | |
MIRNA181A-5P EXPRESSION AS A BIOMARKER OF TGFB PATHWAY ACTIVATION ASSOCIATED WITH ONCOLOGIC OUTCOME AND TUMOR DIFFUSION IN HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER | 1-gen-2017 | Ceppi, L; Palazzi, S; Romualdi, C; Dilorenzo, P; Grassi, T; Biagioli, E; Paracchini, L; Milani, R; Buda, A; D'Incalci, M; Marchini, S; Fruscio, R | |
In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells | 1-gen-2015 | Lupi, M; Falcetta, F; D'Incalci, M; Ubezio, P | |
Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study | 1-gen-2016 | Ferrari, M; Grosso, F; Grignani, G; Ibrahim, T; Tamberi, S; Marra, D; Marchesi, E; Porcu, L; D'Incalci, M; Zucchetti, M | |
MIRNA LANDSCAPE IN STAGE I EPITHELIAL OVARIAN CANCER DEFINES THE HISTOTYPE SPECIFICITIES | 1-gen-2013 | Bignotti, E; Calura, E; Fruscio, R; Paracchini, L; Ravaggi, A; Zanotti, L; Tognon, G; D'Incalci, M; Sartori, E; Pecorelli, S | |
MICRORNA PROFILE IN BONE MARROW FIBROBLASTS FROM PATIENTS WITH MULTIPLE MYELOMA | 1-gen-2015 | Desantis, V; Caparrotta, I; Beltrame, L; Di Marzo, L; Marchini, S; Catacchio, I; D'Incalci, M; Vacca, A; Frassanito, Ma | |
DIAGNOSTIC AND PROGNOSTIC IMPACT OF MICRORNA EXPRESSION IN SERUM OF HIGH-GRADE SEROUS OVARIAN CARCINOMA PATIENTS | 1-gen-2015 | Bignotti, E; Todeschini, P; Ravaggi, A; Ferracin, M; Sartori, E; Odicino, F; Tognon, G; Negrini, M; D'Incalci, M; Marchini, S; Romualdi, C | |
Pharmacokinetics of the Novel FGFR and VEGFR Inhibitor, E-3810, in Patients with Advanced Solid Tumors Participating to a Phase I/II Trial | 1-gen-2012 | Zangarini, M; Sala, F; Camboni, Mg; Cereda, R; Livi, V; Bahleda, R; Dienstmann, R; Delmonte, A; D'Incalci, M; Zucchetti, M | |
OTX015 effects in triple-negative breast cancer (TNBC) models are independent of hypoxia conditions and synergistic with other anticancer agents | 1-gen-2015 | Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Beltrame, L; Marchini, S; Bertoni, F; Kwee, I; Mohamed, M; Cvitkovic, E; Frapolli, R; D'Incalci, M | |
CIRCULATING MIRNA LANDSCAPE IDENTIFIES MIR-1246 AS PROMISING DIAGNOSTIC BIOMARKER IN HIGH-GRADE SEROUS OVARIAN CARCINOMA: A VALIDATION ACROSS TWO INDEPENDENT COHORTS | 1-gen-2017 | Bignotti, E; Todeschini, P; Salviato, E; Paracchini, L; Ferracin, M; Petrillo, M; Zanotti, L; Tognon, G; Gambino, A; Calura, E; Beltrame, L; Odicino, F; Sartori, E; Scambia, G; Negrini, M; Ravaggi, A; D'Incalci, M; Marchini, S; Romualdi, C | |
Activation of TGF-Beta Pathway Through Mir-181a and Psmad-2 Overexpression Drives Resistance To Neoadjuvant Chemotherapy in High Grade Serous Advanced Ovarian Cancer | 1-gen-2015 | Petrillo, M; Marchini, S; Romualdi, C; Beltrame, L; Martinelli, E; Difeo, A; D'Incalci, M; Zannoni, Gf; Scambia, G | |
Insulin-like growth factor binding protein-4 (IGFBP-4) tumor and serum levels are increased across all stages of epithelial ovarian cancer | 1-gen-2012 | Mosig, R; Lobl, M; Cohen, S; Chudin, E; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, J |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...699
Data di pubblicazione
- 2020 - 20219
- 2010 - 2019344
- 2000 - 2009285
- 1990 - 199950
- 1980 - 198911
Editore
- s.n110
- sn21
- Springer4
- AMER SOC CLINICAL ONCOLOGY, 2318 ...3
- IMECHE2
- ISAKOS2
- Oxford University Press2
- s.n.2
- Societá Italiana di Ortopedia e T...2
- 5th Biennal ISAKOS Congress1
Rivista
- ANNALS OF ONCOLOGY23
- JOURNAL OF CLINICAL ONCOLOGY21
- GASTROENTEROLOGY20
- EUROPEAN JOURNAL OF CANCER13
- JOURNAL OF CROHN'S AND COLITIS10
- KNEE SURGERY, SPORTS TRAUMATOLOGY...10
- NEURO-ONCOLOGY10
- INTERNATIONAL JOURNAL OF GYNECOLO...7
- CANCER RESEARCH6
- ITALIAN JOURNAL OF VASCULAR AND E...6
Serie
- IEEE ENGINEERING IN MEDICINE AND ...1
Keyword
- acl reconstruction11
- follow-up4
- knee4
- navigation system4
- ACL RECONSTRUCTION3
- double bundle3
- lca3
- single bundle3
- arthroscopic2
- autologous chondrocyte transplant...2
Lingua
- eng349
- ita116
- fre7
- und3
Accesso al fulltext
- no fulltext672
- reserved27